• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Differentiation between Mycobacterium malmoense and Mycobacterium nonchromogenicum by ethambutol susceptibility].

作者信息

Yamori S, Tsukamura M

出版信息

Kekkaku. 1989 Feb;64(2):95-7.

PMID:2733305
Abstract

Mycobacterium malmoense strains are resistant to 1 microgram/ml ethambutol in Ogawa egg medium, whereas Mycobacterium nonchromogenicum strains are susceptible to this concentration. Therefore, these two Group III nonphotochromogens are differentiated clearly from each other by the susceptibility test for ethambutol 1 microgram/ml. Ninety-five % of Mycobacterium avium complex strains are resistant to this concentration, while M. nonchromogenicum strains are susceptible. Therefore, the test serves for differentiating M. nonchromogenicum from M. avium complex. Previously, Tsukamura (Kekkaku 45: 237, 1970) reported that pathogenic and nonpathogenic mycobacteria of Group II and Group III are differentiated by the susceptibility test to ethambutol, 5 micrograms/ml. However, the use of Ogawa egg medium containing 1 microgram/ml ethambutol is superior to that of 5 micrograms/ml ethambutol for differentiating pathogenic and nonpathogenic ones of the Group III.

摘要

相似文献

1
[Differentiation between Mycobacterium malmoense and Mycobacterium nonchromogenicum by ethambutol susceptibility].
Kekkaku. 1989 Feb;64(2):95-7.
2
[Evaluation of clinical efficacy of isoniazid and ethambutol in the treatment of nontuberculous mycobacteriosis based on in vitro susceptibility testing].基于体外药敏试验评价异烟肼和乙胺丁醇治疗非结核分枝杆菌病的临床疗效
Kekkaku. 1989 Aug;64(8):511-8.
3
[Sulfadimethoxine as a promising drug in the treatment of infections caused by Mycobacterium kansasii and Mycobacterium xenopi--differentiation between M. kansasii and M. marinum and between M. gordonae and M. scrofulaceum by the susceptibility testing to sulfadimethoxine].
Kekkaku. 1989 Apr;64(4):313-7.
4
[A supplement study on the in vitro activity of sulfadimethoxine on Mycobacterium avium complex--combined effect with other antituberculosis drugs].磺胺二甲氧嘧啶对鸟分枝杆菌复合群的体外活性补充研究——与其他抗结核药物的联合效应
Kekkaku. 1989 Jun;64(6):379-86.
5
[Differentiation between pathogenic and nonpathogenic mycobacteria of group II and group 3 by susceptibility to ethambutol].[通过对乙胺丁醇的敏感性鉴别Ⅱ组和Ⅲ组致病性与非致病性分枝杆菌]
Kekkaku. 1970 Aug;45(8):237-40.
6
[Nitrite-Ogawa egg medium for differentiating strains of Mycobacterium nonchromogenicum complex (M. nonchromogenicum, M. terrae and M. triviale) from other slowly growing mycobacteria (author's transl)].
Kekkaku. 1979 Jun;54(6):321-4.
7
[Cross-resistance relationship between streptomycin and kanamycin resistances in Mycobacterium smegmatis (strain Jucho)--comparison of the development patterns of resistances to streptomycin and kanamycin among Mycobacterium tuberculosis, Mycobacterium avium complex, and Mycobacterium smegmatis].耻垢分枝杆菌(Jucho株)中链霉素与卡那霉素耐药性之间的交叉耐药关系——结核分枝杆菌、鸟分枝杆菌复合群和耻垢分枝杆菌中链霉素和卡那霉素耐药性发展模式的比较
Kekkaku. 1990 Dec;65(12):785-9.
8
[Evaluation of cycloserine in the treatment of infections caused by nontuberculous mycobacteria viewed from in vitro experiments].[从体外实验看环丝氨酸治疗非结核分枝杆菌感染的评估]
Kekkaku. 1989 May;64(5):345-9.
9
[Bactericidal activities of rifampicin, ethambutol, enviomycin and streptomycin on Mycobacterium avium-Mycobacterium intracellulare complex strains].利福平、乙胺丁醇、恩维霉素和链霉素对鸟分枝杆菌-胞内分枝杆菌复合群菌株的杀菌活性
Kekkaku. 1990 Aug;65(8):519-25.
10
[In vitro susceptibility testing of nontuberculous mycobacteria to streptomycin, kanamycin and enviomycin].
Kekkaku. 1989 Sep;64(9):557-62.